Maven Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.63K Buy
+100
New +$8.32K ﹤0.01% 576
2026
Q1
– Sell
-23,400
Closed -$1.55M – 449
2025
Q4
$1.55M Buy
+23,400
New +$1.51M 0.03% 336
2025
Q3
– Sell
-7,500
Closed -$655K – 571
2025
Q2
$655K Buy
+7,500
New +$588K 0.02% 538
2025
Q1
– Sell
-10,900
Closed -$848K – 842
2024
Q4
$848K Buy
+10,900
New +$807K 0.02% 462
2024
Q3
– Sell
-2,400
Closed -$272K – 947
2024
Q2
$272K Buy
+2,400
New +$303K 0.01% 811
2024
Q1
– Sell
-7,500
Closed -$931K – 547
2023
Q4
$931K Sell
7,500
-23,700
-76% -$2.42M 0.02% 495
2023
Q3
$2.91M Buy
31,200
+29,600
+1,850% +$3.34M 0.03% 296
2023
Q2
$206K Sell
1,600
-3,000
-65% -$363K ﹤0.01% 815
2023
Q1
$534K Sell
4,600
-1,900
-29% -$213K 0.01% 636
2022
Q4
$736K Sell
6,500
-5,100
-44% -$560K 0.02% 488
2022
Q3
$934K Buy
11,600
+7,300
+170% +$618K 0.02% 564
2022
Q2
$320K Sell
4,300
-2,900
-40% -$265K 0.01% 735
2022
Q1
$921K Sell
7,200
-1,600
-18% -$175K 0.03% 364
2021
Q4
$1.18M Sell
8,800
-9,200
-51% -$1.32M 0.03% 297
2021
Q3
$2.46M Buy
18,000
+6,800
+61% +$858K 0.08% 191
2021
Q2
$1.2M Buy
11,200
+2,800
+33% +$269K 0.05% 374
2021
Q1
$755K Buy
+8,400
New +$789K 0.03% 510
2020
Q4
– Sell
-2,000
Closed -$204K – 650
2020
Q3
$204K Sell
2,000
-1,600
-44% -$167K 0.02% 556
2020
Q2
$365K Buy
+3,600
New +$322K 0.03% 366

Other funds holding DXCM

Maven Securities's DXCM Position: Q3 2026 in Review

Maven Securities opened a new position in DexCom (DXCM) in Q3 2026: 3,494 shares worth $301K. The stake represents ﹤0.01% of the portfolio and ranks #444 among its holdings. This is a return to the name: Maven Securities previously reported a position in DXCM as recently as Q4 2025.

Maven Securities first reported a position in DXCM in Q3 2018 and has held it in 13 quarters since. The position peaked at $1.85M in Q4 2020. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Maven Securities held 3,494 shares of DexCom worth $301K as of Q3 2026.
  • DexCom was a new Maven Securities position in Q3 2026.
  • DexCom made up ﹤0.01% of Maven Securities's portfolio in Q3 2026, its #444 holding.
  • Maven Securities first reported a position in DexCom in Q3 2018 and has held it in 13 quarters since.
  • Maven Securities's DexCom position peaked at $1.85M in Q4 2020.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Maven Securities's 13F filing for Q3 2026, filed 13 Nov 2026.